Skip to main content

Table 3 Quality of life

From: Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial

 

First consultation (T0)

6 months (T2)

6 months (T3)

QoL (Likert-scale)

 Intervention group

0.59 (0.95)

0.56 (0.99)

0.58 (0.93)

 Control group

0.59 (1.00)

0.64 (0.95)

0.66 (1.03)

QoL (VAS)

 Intervention group

67.1 (18.11)

65.9 (17.84)

67.2 (17.13)

 Control group

65.0 (17.71)

67.9 (16.99)

69.0 (17.39) *

QoL (Functional EQ-5D-3L)

 Intervention group

1.49 (0.36)

1.48 (0.36)

1.46 (0.35)

 Control group

1.47 (0.34)

1.43 (0.31)

1.43 (0.33)

  1. Comparison of QoL between groups and different consultations. Numbers given as mean and Standard Deviation (SD). * p < 0.05 (within group comparison between T0 and T3; control group). There is no significant difference between the two groups at any time point. Abbreviations: T0 = First consultation and baseline, T2 = consultation 6 months later, T3 = consultation 12 months later, QoL (Likert-Scale) = scale from − 2 - + 2 (− 2 = the worst possible – + 2 = the best possible) QoL (VAS) = scale from 0 to 100 (0 = the worst possible health status – 100 = the best possible health status) and QoL (Functional EQ-5D-3L) = scale from 0 to 3 (0 = no restriction – 3 = maximum restriction)